Michael Barrowman
Cited by
Cited by
Toward a framework for the design, implementation, and reporting of methodology scoping reviews
GP Martin, DA Jenkins, L Bull, R Sisk, L Lin, W Hulme, A Wilson, W Wang, ...
Journal of Clinical Epidemiology 127, 191-197, 2020
How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies
MA Barrowman, N Peek, M Lambie, GP Martin, M Sperrin
BMC Medical Research Methodology 19 (1), 1-11, 2019
Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect
A Pate, M Barrowman, D Webb, JM Pimenta, KJ Davis, R Williams, ...
BMJ open respiratory research 5 (1), e000339, 2018
Calibration plots for multistate risk predictions models: an overview and simulation comparing novel approaches
A Pate, M Sperrin, RD Riley, N Peek, T Van Staa, JC Sergeant, ...
arXiv preprint arXiv:2308.13394, 2023
Multi-State Clinical Prediction Models in Renal Replacement Therapy
MA Barrowman
PQDT-Global, 2022
Confounding bias in pragmatic trials with a heterogeneous control arm
P Pericleous, M Barrowman, M Sperrin, T van Staa
The system can't perform the operation now. Try again later.
Articles 1–6